Fecal Microbiota Transplantation Is Poised for a Makeover
With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition.
Fecal Microbiota Transplantation Is Poised for a Makeover
Fecal Microbiota Transplantation Is Poised for a Makeover
With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition.
With multiple microbiota therapeutics in the pipeline for recurrent Clostridium difficile infection, clinicians foresee a shift in treatment options for the condition.
Contrary to the popular thought that many species are “unculturable,” the majority of bacteria known to populate the human gut can be grown in the lab, scientists show.
Researchers build a mathematical model that can predict whether a mouse will be infected by Clostridium difficilebased on the microbes found in its GI tract.
Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.